Innovation Scores Big in Maryland
When RemeGenix, Inc., a start-up technology company specializing in the development and commercialization of therapies for neurodegenerative diseases, needed funding to help prepare for clinical trials, they turned to the Maryland Department of Business and Economic Development (DBED) for assistance. The Rockville, Md.-based company, which is focused on determining the cause of illnesses such as Alzheimer’s disease, Dementia, Parkinson’s disease and Traumatic Brain Injury, received a $50,000 investment through DBED’s highly successful Maryland Venture Fund. The company, whose lead product is being developed for Traumatic Brain Injury, hopes to use the funding to help fast track this drug to assist with the number of cases stemming from the war in Iraq. Providing early stage capital investment to start-up technology companies is one of the top priorities of Maryland GovernorMartin O’Malley’s Administration. “The O’Malley-Brown Administration is committed to supporting Maryland’s small... more....